Expertise in
3
conditions

Xiaochun Q. Zhang

No.59 Haier Road, 
Qingdao, CN 
Expertise in
3
conditions
No.59 Haier Road, 
Qingdao, CN 

Overview

Xiaochun Zhang practices practicing medicine in Qingdao, China.

Zhang is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

They are actively involved in clinical research, co-authoring 110 peer reviewed articles and participating in 1 clinical trial.

Locations

No.59 Haier Road, Qingdao, 266000, China
Other Locations
No. 59 Haier Road, Qingdao, China
No. 59 Haier Road, Qingdao, 266000, China
16 Jiangsu Road, Qingdao, 266000, China
No. 59 Haier Road, Qingdao, 266016, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 3

110 Total Publications

The Paternò-Büchi Reaction Diversifies Rifamycin Scaffolds and Enhances Antibacterial Activity.
The Paternò-Büchi Reaction Diversifies Rifamycin Scaffolds and Enhances Antibacterial Activity.
Journal: Organic letters
Published: August 02, 2026

Frequently Asked Questions about Xiaochun Q. Zhang

Is Xiaochun Q. Zhang a top-rated expert for Squamous Cell Lung Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Xiaochun Q. Zhang is classified as an Advanced expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xiaochun Q. Zhang participate in research or clinical trials?

Yes. Xiaochun Q. Zhang has published 110 articles and abstracts on conditions like Squamous Cell Lung Carcinoma. You can view a list of Xiaochun Q. Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhang's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile